JP2022502378A5 - - Google Patents
Info
- Publication number
- JP2022502378A5 JP2022502378A5 JP2021516619A JP2021516619A JP2022502378A5 JP 2022502378 A5 JP2022502378 A5 JP 2022502378A5 JP 2021516619 A JP2021516619 A JP 2021516619A JP 2021516619 A JP2021516619 A JP 2021516619A JP 2022502378 A5 JP2022502378 A5 JP 2022502378A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- composition
- composition according
- combination
- hydrogen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862736246P | 2018-09-25 | 2018-09-25 | |
| US62/736,246 | 2018-09-25 | ||
| PCT/US2019/052410 WO2020068657A1 (en) | 2018-09-25 | 2019-09-23 | 2'-halogenated-4'-thio-2'-deoxy-5-azacytidine analogs and use thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022502378A JP2022502378A (ja) | 2022-01-11 |
| JP2022502378A5 true JP2022502378A5 (cg-RX-API-DMAC7.html) | 2022-09-08 |
| JP7520822B2 JP7520822B2 (ja) | 2024-07-23 |
Family
ID=68136598
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021516619A Active JP7520822B2 (ja) | 2018-09-25 | 2019-09-23 | 2’-ハロゲン化-4’-チオ-2’-デオキシ-5-アザシチジンアナログおよびその使用 |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US20220033387A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3856754A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP7520822B2 (cg-RX-API-DMAC7.html) |
| CN (1) | CN112888698A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2019349424B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3110224A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2020068657A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2020068657A1 (en) * | 2018-09-25 | 2020-04-02 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | 2'-halogenated-4'-thio-2'-deoxy-5-azacytidine analogs and use thereof |
| AU2021260964A1 (en) | 2020-04-23 | 2022-12-01 | Pinotbio, Inc. | Composition for treating blood cancer using 4'-thio-5-aza-2'-deoxycytidine and uses thereof |
| CN114644668B (zh) * | 2020-12-18 | 2026-04-14 | 鲁南制药集团股份有限公司 | 一种合成地西他滨的方法 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4675189A (en) | 1980-11-18 | 1987-06-23 | Syntex (U.S.A.) Inc. | Microencapsulation of water soluble active polypeptides |
| JPS60100516A (ja) | 1983-11-04 | 1985-06-04 | Takeda Chem Ind Ltd | 徐放型マイクロカプセルの製造法 |
| CA1256638A (en) | 1984-07-06 | 1989-06-27 | Motoaki Tanaka | Polymer and its production |
| JP2551756B2 (ja) | 1985-05-07 | 1996-11-06 | 武田薬品工業株式会社 | ポリオキシカルボン酸エステルおよびその製造法 |
| WO1997038001A1 (en) * | 1996-04-09 | 1997-10-16 | Yamasa Corporation | 1-(2-DEOXY-2-FLUORO-4-THIO-β-D-ARABINOFURANOSYL)CYTOSINES |
| CA2585125C (en) * | 2004-10-25 | 2014-04-22 | Lee Morgan | Salts of isophosphoramide mustard and analogs thereof as anti-tumor agents |
| US20060128654A1 (en) * | 2004-12-10 | 2006-06-15 | Chunlin Tang | Pharmaceutical formulation of cytidine analogs and derivatives |
| US7700567B2 (en) * | 2005-09-29 | 2010-04-20 | Supergen, Inc. | Oligonucleotide analogues incorporating 5-aza-cytosine therein |
| MY156954A (en) * | 2009-12-18 | 2016-04-15 | Libramedicina Inc | PROCESS FOR PREPARING SUBSTITUTED 1-O-ACYL-2-DEOXY-2-FLUORO-4-THIO-ß-D-ARABINOFURANOSES |
| KR101770246B1 (ko) * | 2012-03-28 | 2017-08-22 | 후지필름 가부시키가이샤 | 1-(2-디옥시-2-플루오로-4-티오-β-D-아라비노푸라노실)시토신의 염 |
| HRP20190572T1 (hr) * | 2012-08-13 | 2019-05-17 | Fujifilm Corporation | POSREDNIK ZA SINTEZU 1-(2-DEOKSI-2 FLUORO-4-TIO-beta-D-ARABINOFURANOZIL) CITOZINA, POSREDNIK ZA SINTEZU TIONUKLEOZIDA, I METODE ZA PROIZVODNJU OVIH POSREDNIKA |
| CN103626765B (zh) * | 2012-08-27 | 2016-08-10 | 广东东阳光药业有限公司 | 取代的氮杂吲哚化合物及其盐、组合物和用途 |
| WO2015125781A1 (ja) | 2014-02-18 | 2015-08-27 | 富士フイルム株式会社 | チオラン骨格型糖化合物の製造方法およびチオラン骨格型糖化合物 |
| JP6450356B2 (ja) * | 2016-02-29 | 2019-01-09 | 富士フイルム株式会社 | 液状医薬製剤 |
| JP7425734B2 (ja) | 2018-02-01 | 2024-01-31 | ザ ユナイテッド ステイツ オブ アメリカ, アズ リプレゼンテッド バイ ザ セクレタリー, デパートメント オブ ヘルス アンド ヒューマン サービシーズ | 2’-デオキシヌクレオシドを製造するための立体選択的合成およびプロセス |
| WO2020068657A1 (en) * | 2018-09-25 | 2020-04-02 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | 2'-halogenated-4'-thio-2'-deoxy-5-azacytidine analogs and use thereof |
-
2019
- 2019-09-23 WO PCT/US2019/052410 patent/WO2020068657A1/en not_active Ceased
- 2019-09-23 CA CA3110224A patent/CA3110224A1/en active Pending
- 2019-09-23 CN CN201980062607.3A patent/CN112888698A/zh active Pending
- 2019-09-23 EP EP19782886.6A patent/EP3856754A1/en not_active Withdrawn
- 2019-09-23 JP JP2021516619A patent/JP7520822B2/ja active Active
- 2019-09-23 US US17/278,625 patent/US20220033387A1/en not_active Abandoned
- 2019-09-23 AU AU2019349424A patent/AU2019349424B2/en not_active Ceased
-
2021
- 2021-06-09 US US17/343,350 patent/US11254662B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6075903B2 (ja) | Pfkfb2阻害剤および抗癌治療法としての使用方法 | |
| JP2008535902A5 (cg-RX-API-DMAC7.html) | ||
| US9464093B2 (en) | Substituted imidazo[4',5':4,5]cyclopenta[1,2-e]pyrrolo[1,2-a]pyrazines and oxazolo[4',5':4,5]cyclopenta[1,2-e]pyrrolo[1,2-a]pyrazines for treating brain cancer | |
| BR112019017962A2 (pt) | método para inibição de crescimento, de migração, de proliferação e/ou de metástase de uma célula pré-cancerosa, cancerosa ou neoplásica ou de inibição de um patógeno, composição probiótica tópica, bandagem ou curativo, método de tratamento de dano na pele devido à radiação uv, e, composição farmacêutica | |
| JP4852605B2 (ja) | 放射線治療増強剤 | |
| GB2576120A (en) | Novel quinazolinone derivatives inhibiting PI3K and pharmaceutical composition containing same | |
| JP6606806B2 (ja) | 重水素化キナゾリノン化合物及び該化合物を含む薬物組成物 | |
| JP2023546316A5 (cg-RX-API-DMAC7.html) | ||
| JPH05163148A (ja) | 抗腫瘍剤 | |
| JP6450678B2 (ja) | 新規な化合物およびその使用 | |
| JP2013523867A5 (cg-RX-API-DMAC7.html) | ||
| CN105949149A (zh) | 用于治疗或预防乳腺癌的化合物 | |
| EP2902028A1 (en) | Drug composition for treating tumors and application thereof | |
| US12338204B2 (en) | Substituted bisphenylalkylurea compounds and methods of treating breast cancer | |
| KR20230010349A (ko) | 사이티딘 탈아미노효소 억제 활성을 갖는 신규한 테트라하이드로우리딘 유도체 | |
| JP7733273B2 (ja) | G12d変異kras阻害活性を有する二官能性化合物を含む抗がん剤の組合せ | |
| WO2020254299A1 (en) | Combination of a mcl-1 inhibitor and a standard of care treatment for breast cancer, uses and pharmaceutical compositions thereof | |
| US11312699B2 (en) | Processes for preparing 2-(4-chlorophenyl)-N-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl)methyl)-2,2-difluoroacetamide | |
| CN110573620A (zh) | 血癌治疗剂 | |
| JP2008540585A (ja) | 転移性メラノーマ及び他の癌を治療するための化合物、そのような化合物を含有する組成物、および治療方法 | |
| CN119320354B (zh) | hnRNPA2B1激动剂及其与化疗剂联用的肿瘤防治应用 | |
| US20260034115A1 (en) | Yap1 inhibitors | |
| CN111777621B (zh) | 喹唑啉衍生物类酪氨酸激酶抑制剂的新用途 | |
| HK40126492A (en) | Enantiomer of azopodophyllotoxin derivative su056 | |
| JP5249753B2 (ja) | ジカルボン酸誘導体、転移阻害剤および抗腫瘍調製物の化学療法活性を増大する薬剤、細胞増殖抑制剤の効果を増大する方法および転移プロセスの阻害のための方法 |